AMENDMENT TO THE EXECUTIVE- AND BUSINESS MANAGER EMPLOYMENT CONTRACT between Prima BioMed GmbH, Leipzig, Local Court Leipzig HRB 27135 (the “Company”) and Marc Voigt (the “Managing Director” or “Mr. Voigt”) (the Company and the Managing Director...Prima BioMed LTD • October 3rd, 2016 • Pharmaceutical preparations
Mr Marc Voigt Managing Director and Chief Executive Officer Prima BioMed LimitedEmployment Agreement • October 3rd, 2016 • Prima BioMed LTD • Pharmaceutical preparations
SUB-LICENSE, LICENSE AND ASSET PURCHASE AGREEMENT by and between PRIMA BIOMED LTD and SYDYS CORPORATION Dated as of 11 / 12 May 2016Asset Purchase Agreement • October 3rd, 2016 • Prima BioMed LTD • Pharmaceutical preparations • New York
This Sub-License, License and Asset Purchase Agreement (this “Agreement”) is made and entered into as of 11/12 May 2016 (the “Effective Date”), by and among Prima Biomed Ltd ACN 009 237 889 (“Seller”), an Australian corporation listed on the Australian Securities Exchange and on the NASDAQ in the US, and Sydys Corporation, a Nevada corporation listed on the OTC Market under the symbol SYYC (“Purchaser”). Seller and Purchaser are herein referred to individually as a “Party” and collectively as the “Parties.”
Level 12, 95 Pitt Street Sydney NSW 2000 AustraliaPrima BioMed LTD • October 3rd, 2016 • Pharmaceutical preparations
